PKP2表达在运动相关致心律失常性右室心肌病进展中的作用:一项转化研究
该转化研究探讨耐力运动对PKP2条件性敲除小鼠转录组的影响,发现运动下调闰盘蛋白编码基因,与PKP2缺失效应汇聚;PKP2缺失导致收缩缺陷、肌肉质量减少及凋亡信号增加,运动加速心功能障碍,而预训练可减轻该效应;携带PKP2突变运动员心脏尺寸较匹配对照减小。
要点
- 运动可下调闰盘蛋白基因表达,与PKP2缺失的转录组变化汇聚。
- PKP2缺失小鼠出现收缩缺陷、肌肉质量减少及凋亡信号增加。
- 运动加速PKP2缺失小鼠心功能障碍,预训练可减轻该效应。
核心结论
- 研究者推测运动挑战心肌细胞「桥粒储备」,若遗传受损(如PKP2缺失)则加速心肌病进展。
研究设计与样本
- 转化研究:对PKP2条件性敲除小鼠与对照进行耐力训练,比较转录组变化。
- 纳入携带PKP2突变的人类运动员与匹配对照比较心脏尺寸。
主要发现
- 单纯运动导致编码闰盘蛋白基因转录下调,该变化与久坐及运动PKP2cKO小鼠的变化汇聚。
- PKP2缺失导致心脏收缩缺陷、肌肉质量减少及凋亡的功能/转录组特征增加,尽管单心肌细胞缩短分数和钙瞬变幅度增加。
- 运动加速PKP2缺失小鼠心功能障碍,而在PKP2敲除前预训练可减弱该效应。
- 携带PKP2突变的人类运动员心脏尺寸较匹配对照减小。
临床怎么用
- 对携带PKP2突变者,运动可能加速心肌病进展,预训练可能减轻PKP2缺失后的心功能障碍。
局限性
- 机制推论基于小鼠模型与人类观察,尚需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Exercise increases arrhythmia risk and cardiomyopathy progression in arrhythmogenic right ventricular cardiomyopathy (ARVC) patients, but the mechanisms remain unknown. We investigated transcriptomic changes caused by endurance training in mice deficient in plakophilin-2 (PKP2cKO), a desmosomal protein important for intercalated disc formation, commonly mutated in ARVC and controls. METHODS AND RESULTS: Exercise alone caused transcriptional downregulation of genes coding intercalated disk proteins. The changes converged with those in sedentary and in exercised PKP2cKO mice. PKP2 loss caused cardiac contractile deficit, decreased muscle mass and increased functional/transcriptomic signatures of apoptosis, despite increased fractional shortening and calcium transient amplitude in single myocytes. Exercise accelerated cardiac dysfunction, an effect dampened by pre-training animals prior to PKP2-KO. Consistent with PKP2-dependent muscle mass deficit, cardiac dimensions in human athletes carrying PKP2 mutations were reduced, compared to matched controls. CONCLUSIONS: We speculate that exercise challenges a cardiomyocyte "desmosomal reserve" which, if impaired genetically (e.g., PKP2 loss), accelerates progression of cardiomyopathy.
引用
- Cerrone M, Marrón-Liñares GM, van Opbergen CJM, et al. Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study. Eur Heart J. 2022. PMID: 34932122. doi:10.1093/eurheartj/ehab772
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。